In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, VP, Emerging Therapies, Cencora, discusses the unique challenges that developers of cell and gene therapies need to plan for when building their channel strategy.
Planning for Unique Challenges Faced by Cell & Gene Therapy Developers
Posted on by admin
1 min read
+ There are no comments
Add yours